Tweet
dear all
i have problem in building the database manually in snpeff database
i have problem in building the database manually in snpeff database
-
-
You need to provide additional information before people can help.
What command are you running? What error do you get (if any)? -
SNPeff database building error
java.lang.RuntimeException: FATAL ERROR: Most Exons do not have sequences!
There might be differences in the chromosome names used in the genes file ('/home/crpgws2/Desktop/snpEff/./data/ver6/genes.gff')
and the chromosme names used in the 'reference sequence' file.
Please check that chromosome names in both files match.
I got this error while running the snpeff database building command. Should I modify my chromosome name in ref seq or I have to modify the gff file. I am doing this to create Vigna radiata reference. Please let me know what can i do to solve this problem.Comment
-
Comment
-
I have run SNPeff successfully. but i found some problem in html output file, as my input VCF line number and variants before filter are two different numbers. While in my view that must be same. What can be the reason for this variation although In my Input vcf and output vcf have the same no. of entries, but still the html stats varies from this number.
Summary
Genome ver6
Date 2017-04-05 11:58
SnpEff version
SnpEff 4.3k (build 2017-03-29 17:16), by Pablo Cingolani
Command line arguments
SnpEff ver6 VIGNA_SUBLOBATA_SNV.vcf
Warnings 70,058
Errors 0
Number of lines (input file) 100,273
Number of variants (before filter) 104,184
Number of not variants
(i.e. reference equals alternative) 0
Number of variants processed
(i.e. after filter and non-variants) 103,341
Number of known variants
(i.e. non-empty ID) 0 ( 0% )
Number of multi-allelic VCF entries
(i.e. more than two alleles) 1,382
Number of effects 223,468
Genome total length 463,637,892
Genome effective length 333,860,997
Variant rate 1 variant every 3,230 basesComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment